ATLANTA, Jan. 23, 2026 (GLOBE NEWSWIRE) — Dr. Taz Bhatia M.D., a nationally recognized integrative medicine physician, author, and founder of hol+, has partnered with nonprofit Countdown for a Cure (CFAC) to help advance [...] Read more »
Attindas Hygiene Partners Amplia Parceira na Europa com Importante Aquisição
RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Attindas Hygiene Partners dá um passo importante para sua estratégia de crescimento hoje com a aquisição da Societá Italiana [...] Read more »
Attindas Hygiene Partners renforce sa position en Europe grâce à une acquisition stratégique
RALEIGH, Caroline du Nord, 10 janv. 2026 (GLOBE NEWSWIRE) — Attindas Hygiene Partners exécute aujourd’hui une étape majeure dans sa stratégie de croissance avec l’acquisition de Società [...] Read more »
Attindas Hygiene Partners baut mit bedeutender Akquisition seine Position in Europa aus
RALEIGH, North Carolina, Jan. 10, 2026 (GLOBE NEWSWIRE) — Die Wachstumsstrategie von Attindas Hygiene Partners hat heute mit der Übernahme von Società Italiana Lavorazione Cellulosa (SILC S.p.A.) einen wichtigen [...] Read more »
Attindas Hygiene Partners Expands European Position with Key Acquisition
RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Attindas Hygiene Partners’ growth strategy realized an important step forward today with its acquisition of Societá Italiana Lavorazione Cellulosa (SILC [...] Read more »
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
- REC–4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)
- After 12 weeks [...] Read more »
Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response
WASHINGTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3–Marburg Vaccine to Ethiopia to support the [...] Read more »
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
HAIFA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical–stage biotechnology company developing novel therapies to treat [...] Read more »
شركة Profound Medical توقع اتفاقية توزيع حصرية لمنتجات TULSA-PRO®وSonalleve® مع شركة Al Faisaliah Medical Systems في المملكة العربية السعودية
الاتفاقية تفتح المجال أمام علاجات [...] Read more »
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
Agreement creates runway for Profound’s incision–free and radiation–free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East
Read more »